169 related articles for article (PubMed ID: 20031934)
41. Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis.
Papadopoulou E; Hansel J; Lazar Z; Kostikas K; Tryfon S; Vestbo J; Mathioudakis AG
Eur Respir Rev; 2023 Mar; 32(167):. PubMed ID: 36697209
[TBL] [Abstract][Full Text] [Related]
42. A review of national guidelines for management of COPD in Europe.
Miravitlles M; Vogelmeier C; Roche N; Halpin D; Cardoso J; Chuchalin AG; Kankaanranta H; Sandström T; Śliwiński P; Zatloukal J; Blasi F
Eur Respir J; 2016 Feb; 47(2):625-37. PubMed ID: 26797035
[TBL] [Abstract][Full Text] [Related]
43. Antioxidants and mucolytics in COPD management: when (if ever) and in whom?
Hillas G; Nikolakopoulou S; Hussain S; Vassilakopoulos T
Curr Drug Targets; 2013 Feb; 14(2):225-34. PubMed ID: 23256719
[TBL] [Abstract][Full Text] [Related]
44. [Effects of mucolytic agents and macrolides in the treatment of COPD].
Yamaya M
Nihon Rinsho; 2016 May; 74(5):833-8. PubMed ID: 27254955
[TBL] [Abstract][Full Text] [Related]
45. Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD): A practice review.
Fu Y; Chapman EJ; Boland AC; Bennett MI
Palliat Med; 2022 May; 36(5):770-782. PubMed ID: 35311415
[TBL] [Abstract][Full Text] [Related]
46. Clinical issues of mucus accumulation in COPD.
Ramos FL; Krahnke JS; Kim V
Int J Chron Obstruct Pulmon Dis; 2014; 9():139-50. PubMed ID: 24493923
[TBL] [Abstract][Full Text] [Related]
47. Mucoactive drugs for asthma and COPD: any place in therapy?
Rogers DF
Expert Opin Investig Drugs; 2002 Jan; 11(1):15-35. PubMed ID: 11772318
[TBL] [Abstract][Full Text] [Related]
48. Mucoactive drugs in the management of chronic obstructive pulmonary disease.
Del Donno M; Olivieri D
Monaldi Arch Chest Dis; 1998 Dec; 53(6):714-9. PubMed ID: 10063352
[TBL] [Abstract][Full Text] [Related]
49. Carbocisteine for acute exacerbations of COPD.
Waller P; Suissa S
Lancet; 2008 Nov; 372(9650):1630; author reply 1631-2. PubMed ID: 18994655
[No Abstract] [Full Text] [Related]
50. Mucolytic agents for COPD and chronic bronchitis.
Molle E
Am J Nurs; 2013 Jul; 113(7):23. PubMed ID: 23803930
[TBL] [Abstract][Full Text] [Related]
51. An update on chronic obstructive pulmonary disease.
Pleasants RA; Haden D
Consult Pharm; 2005 Nov; 20(11):965-75. PubMed ID: 16548673
[TBL] [Abstract][Full Text] [Related]
52. An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?
Cazzola M; Rogliani P; Puxeddu E; Ora J; Matera MG
Expert Rev Respir Med; 2018 Jan; 12(1):43-54. PubMed ID: 29082808
[TBL] [Abstract][Full Text] [Related]
53. Acute exacerbations of COPD. How to evaluate severity and treat the underlying cause.
Hagedorn SD
Postgrad Med; 1992 Jan; 91(1):105-7, 110-2. PubMed ID: 1345880
[TBL] [Abstract][Full Text] [Related]
54. Mucoactive drugs and multiple applications in pulmonary disease therapy.
Hocquigny A; Hugerot H; Ghanem R; Haute T; Laurent V; Cogulet V; Montier T
Eur J Pharm Biopharm; 2024 Jan; 194():110-117. PubMed ID: 38048888
[TBL] [Abstract][Full Text] [Related]
55. Revisited role for mucus hypersecretion in the pathogenesis of COPD.
Cerveri I; Brusasco V
Eur Respir Rev; 2010 Jun; 19(116):109-12. PubMed ID: 20956178
[TBL] [Abstract][Full Text] [Related]
56. Role of N-acetylcysteine in the management of COPD.
Sadowska AM; Verbraecken J; Darquennes K; De Backer WA
Int J Chron Obstruct Pulmon Dis; 2006; 1(4):425-34. PubMed ID: 18044098
[TBL] [Abstract][Full Text] [Related]
57. Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease.
Calzetta L; Matera MG; Rogliani P; Cazzola M
Expert Rev Respir Med; 2018 Aug; 12(8):693-708. PubMed ID: 29972340
[TBL] [Abstract][Full Text] [Related]
58. Management of patients with COPD.
Medford AR
Lancet; 2004 Dec 4-10; 364(9450):2016. PubMed ID: 15582053
[No Abstract] [Full Text] [Related]
59. Emerging drugs for the treatment of chronic obstructive pulmonary disease.
Malhotra S; Man SF; Sin DD
Expert Opin Emerg Drugs; 2006 May; 11(2):275-91. PubMed ID: 16634702
[TBL] [Abstract][Full Text] [Related]
60. The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease.
Hooper C; Calvert J
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):659-69. PubMed ID: 19281081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
